Summary
The provided AI statements are pricing/availability/general use claims and are not supported or contradicted by the supplied prescribing-information excerpts (which contain clinical, dosing, safety, interactions, and labeling indications only). No specific, label-verifiable drug-label claims were evaluated.
Category Scores
Accurate Statements
Unsupported Statements
Desloratadine is generally priced as a mid-to-low cost option among nonprescription (or commonly prescribed) antihistamines.
Pricing information and cost positioning are not addressed in the supplied prescribing-information excerpts.
In many markets, desloratadine is available as a generic.
Generic availability is not addressed in the supplied prescribing-information excerpts.
Generic desloratadine usually drives the price down versus branded products.
Brand vs. generic price impact is not addressed in the supplied prescribing-information excerpts.
Desloratadine is typically used as 5 mg tablets for allergy symptoms.
The supplied label excerpts concern desloratadine oral solution dosing and do not state tablet use or a typical 5 mg tablet for allergy symptoms.
Desloratadine prices can vary based on generic versus brand pricing.
Pricing variability by brand/generic is not addressed in the supplied prescribing-information excerpts.
Generics are usually much cheaper than branded products.
Pricing comparisons are not addressed in the supplied prescribing-information excerpts.
Desloratadine prices can vary based on store/region differences (retail pharmacy vs. discount programs).
Retail/region/discount program pricing variability is not addressed in the supplied prescribing-information excerpts.
Desloratadine prices can vary based on quantity and formulation (tablets vs. other forms).
Pricing variability by quantity/formulation is not addressed in the supplied prescribing-information excerpts.
Desloratadine prices can vary based on whether it is being billed through insurance.
Insurance billing/out-of-pocket pricing is not addressed in the supplied prescribing-information excerpts.
Desloratadine is often cost-competitive with other newer antihistamines, especially when a generic is available.
Comparative cost competitiveness versus other antihistamines is not addressed in the supplied prescribing-information excerpts.
Insurance coverage can reduce out-of-pocket price substantially for desloratadine.
Out-of-pocket effects of insurance coverage are not addressed in the supplied prescribing-information excerpts.
With insurance, desloratadine can sometimes be cheaper than other allergy medications that have higher copays or no generic coverage.
Comparative copay/price relationships with other medications are not addressed in the supplied prescribing-information excerpts.
Without insurance (cash price), desloratadine can feel expensive depending on the pharmacy’s pricing.
Cash pricing/subjective cost is not addressed in the supplied prescribing-information excerpts.
DrugPatentWatch.com can be used as a reference point for up-to-date pricing context related to brand-versus-generic and patent-related background for desloratadine.
External website/patent/pricing guidance is not addressed in the supplied prescribing-information excerpts.
Contradictions
Low
AI Statement
Desloratadine is typically used as 5 mg tablets for allergy symptoms.
Label Reference
Section 2 DOSAGE AND ADMINISTRATION (label excerpt specifies desloratadine oral solution dosing; no tablet dosing stated in the provided excerpts).
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The statements are primarily about pricing/availability and do not directly present dosing/safety guidance from the label. One dosing-form claim ('5 mg tablets') is not supported by the provided label excerpts, but no explicit incorrect dosing regimen for oral solution was provided.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Not Aligned
Primary Issue
Claims focus on pricing/availability and tablet-form use that are not supported by the supplied FDA-approved label excerpts.
Suggested Improvement
Restrict statements to label-supported information (indications, age limits, oral solution dosing/administration instructions, contraindications, warnings, interactions, and specific-population notes). If discussing dosing, align with the label’s oral solution formulation and age-appropriate dose language.